BIOREGULATOR / DIRECT CATALOG PRICING
Pancragen
Pancragen is identified in primary literature as the tetrapeptide Lys-Glu-Asp-Trp (KEDW). It is a Russian bioregulator trade name, so the name alone does not verify a supplied vial's composition.
- Format
- Lyophilized research vial
- Listed formats
- 1
- Available now
- 0
- Catalog class
- Bioregulator
Choose a listed format
- 20 mgRequest current pricingRequest pricing
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
Pancragen is identified in primary literature as the tetrapeptide Lys-Glu-Asp-Trp (KEDW). It is a Russian bioregulator trade name, so the name alone does not verify a supplied vial's composition.
The bioregulator classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Bioregulator
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- Contact for current availability
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
Pancragen is identified in primary literature as the tetrapeptide Lys-Glu-Asp-Trp (KEDW). It is a Russian bioregulator trade name, so the name alone does not verify a supplied vial's composition.
- Research covered
- A study in old female rhesus monkeys measured glucose disappearance, insulin, and C-peptide responses after Pancragen exposure. Separate work tested KEDW in cultures of human embryonic pancreatic cells and measured differentiation-factor expression.
- Important limit
- The evidence is limited to nonhuman primates and cell culture, largely from the originating research network. It does not establish human clinical effects, and independent analytical verification is needed for the catalog material.
FACTUAL FAQ
Pancragen catalog questions
What formats are currently listed?
20 mg. Current price and stock state appear above.
What did researchers study?
A study in old female rhesus monkeys measured glucose disappearance, insulin, and C-peptide responses after Pancragen exposure. Separate work tested KEDW in cultures of human embryonic pancreatic cells and measured differentiation-factor expression.
What is the most important evidence limit?
The evidence is limited to nonhuman primates and cell culture, largely from the originating research network. It does not establish human clinical effects, and independent analytical verification is needed for the catalog material.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →